Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NEC Laboratories Europe specializes in advanced artificial intelligence and machine learning technologies with strong applications in digital health. Its key contributions include the development of the neoantigen prediction pipeline used by partners to advance personalized therapeutic cancer vaccines into early clinical trials. The lab also collaborates on AI-driven diagnostic tools that enhance preventive healthcare and early intervention across multiple indications including oncology, infectious diseases, neurodegenerative disorders, and long COVID. It acts primarily as an innovation hub within the broader NEC Group ecosystem rather than a standalone biotech/pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEC Laboratories Europe.